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Arthroscopic Partial Meniscectomy for Degenerative
Meniscal Tear
To the Editor: Previous studies have suggested
that partial meniscectomy has little benefit in
patients with advanced osteoarthritis1,2 but some
benefit in those with mild-to-moderate osteoarthritis.3 Sihvonen and colleagues (Dec. 26 issue)4
attempted to assess the benefit of partial meniscectomy in patients without osteoarthritis.
However, although the authors excluded patients with radiographic degenerative changes,
the declaration of “no knee osteoarthritis” is misleading. It is important to note that patients in
this study did have cartilage degeneration. In fact,
80% of the patients in the partial-meniscectomy
group and 67% of those in the sham group had
degenerative or osteoarthritic changes on diagnostic arthroscopy. In addition, patients with
traumatic tears or mechanical symptoms were
excluded, yet this is probably the group that
would benefit most from arthroscopic partial
meniscectomy.5 Lastly, magnetic resonance imaging (MRI) was not used to exclude or stratify
patients according to factors such as subchondral edema or chondromalacia.
We submit that arthroscopy remains an effective treatment for meniscal tears in selected patients. Surgical decision making should be individualized, including consideration of mechanical
symptoms, degenerative versus traumatic meniscal tear, and other pain generators, including
the degree of arthritis.
Aaron J. Krych, M.D.
Michael J. Stuart, M.D.
Bruce A. Levy, M.D.
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To the Editor: The Finnish Degenerative Meniscal Lesion Study (FIDELITY) Group conducted a
surgical prospective, blinded, randomized trial.
Their data are persuasive that the combination of
knee pain and a meniscal tear confirmed on MRI
does not warrant an arthroscopic partial meniscectomy. It would be a mistake, however, to extrapolate a conclusion that partial meniscectomy is inappropriate for all patients with degenerative tears.
Mechanical symptoms are an important primary problem that arthroscopic meniscectomy
can alleviate. Such symptoms were reported by
less than half the patients in this study, and a
locked knee was an exclusion criterion, according
to data in the Supplementary Appendix (available with the full text of the article at NEJM.org).
The American Academy of Orthopaedic Surgeons (AAOS) has recently created appropriateuse criteria for osteoarthritis of the knee.1 Rather
than MRI evidence, mechanical symptoms were
the trigger for recommendations for arthroscopic meniscectomy. The appropriate-use criteria, in
which a high level of appropriateness was given
for arthroscopy, conflict with the results of this
study. We hope future studies will address the
important role of mechanical symptoms.
David S. Jevsevar, M.D., M.B.A.
Intermountain Zion Orthopaedics and Sports Medicine
St. George, UT
david.jevsevar@imail.org
University of Pittsburgh School of Medicine
Pittsburgh, PA

James O. Sanders, M.D.
University of Rochester Medical Center School of Medicine
and Dentistry
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1. American Academy of Orthopaedic Surgeons. Appropriate

use criteria on non-arthroplasty treatment of osteoarthritis of
the knee. Rosemont, IL, American Academy of Orthopaedic
Surgeons, December 2013 (http://www.aaos.org/research/
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To the Editor: We are concerned that the study
by Sihvonen and colleagues will be interpreted by
many to indicate that surgery for a meniscal tear
does not work. However, five study sites required
more than 5 years to enroll 205 patients. The
authors did not provide the numbers of patients
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who did not meet the inclusion criteria but still
received medial (not lateral) meniscectomies.
Also, both treatment groups had meaningful improvements; we believe this may be explained by
the nature of the sham control — not a true
sham, but arthroscopic lavage, which is an accepted surgical procedure. The study did not examine whether arthroscopic partial meniscectomy is effective but whether it is more effective
than arthroscopic lavage without arthroscopic
partial meniscectomy. Given the diagnostic difficulty in distinguishing between degenerative
and acute meniscal tears clinically, as well as the
low generalizability of the findings, the authors’
conclusions that “these results argue against the
current practice of performing arthroscopic partial meniscectomy in patients with degenerative
meniscal tear” is too broad.
Christian Lattermann, M.D.
University of Kentucky
Lexington, KY
clatt2@uky.edu
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The Authors Reply: Krych et al. point out that the
majority of patients in our trial had cartilage degeneration on arthroscopy. However, we disagree
that our description of “no knee osteoarthritis”
was misleading, since arthroscopically determined
cartilage degeneration is not considered osteoarthritis by any currently used clinical criteria.
We also disagree with the notion that patients with traumatic tears or mechanical symptoms were excluded from our trial. Although true
traumatic onset of symptoms was an exclusion
criterion, in 16% of our patients the onset was
sudden or after twisting, and 47% had preoperative mechanical symptoms. We are aware that
such patients are widely considered to be the
group most likely to benefit from arthroscopic
partial meniscectomy. Krych et al. refer to a recent survey evaluating clinical decision making
for arthroscopic partial meniscectomy among
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practicing orthopedic surgeons, in which mechanical symptoms were not even included owing to the presumption that they would be unanimously considered a definite surgical indication.
As noted by Jevsevar et al., the AAOS shares this
stance.1 However, compelling evidence is lacking
to support the assumption that mechanical symptoms are caused by degenerative meniscal tears
or that they can be alleviated by arthroscopic
partial meniscectomy in these patients.
Krych et al. state that subchondral edema and
chondromalacia could affect the outcome of arthroscopic partial meniscectomy. Although this
is possible, to our knowledge, no conclusive evidence exists to support such assumptions in this
particular patient population. Reliable testing of
hypotheses like these would require that criteria
for these potential prognostic factors first be
accepted and validated.
In response to Lattermann et al.: we emphasize that FIDELITY was designed as an efficacy
(proof-of-concept) trial with the intention of recruiting not typical patients undergoing arthro
scopic partial meniscectomy but rather patients
most likely to have a good response (those with
a medial meniscal tear but no osteoarthritis).
This also explains the lengthy recruitment period
despite the participation of five high-volume
centers. Although the study design has been
elaborated in detail previously,2 we briefly note
that an efficacy trial assesses whether an intervention — here, arthroscopic partial meniscectomy — can theoretically work under the best
circumstances. If the results are negative, this
suggests that it is not necessary to assess effectiveness in less optimal, routine settings.3 With

respect to the concern that lavage was not an
appropriate control, the existing high-quality
evidence is unambiguous: tidal irrigation4 and
arthroscopic lavage5 have failed to provide a
benefit over sham procedures (sham irrigation
and skin incisions, respectively) in randomized
trials involving patients with osteoarthritis. The
AAOS seems to endorse this view.1
Teppo L.N. Järvinen, M.D., Ph.D.
Helsinki University Central Hospital
Helsinki, Finland
teppo.jarvinen@helsinki.fi
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Abatacept in B7-1–Positive Proteinuric Kidney Disease
To the Editor: In their Brief Report, Yu et al.
(Dec. 19 issue)1 describe the use of abatacept, an
inhibitor of the T-cell costimulatory molecule
B7-1, in inducing remission in five patients with
focal segmental glomerulosclerosis (FSGS) resistant to rituximab and glucocorticoids (one patient
with primary FSGS and four with recurrent FSGS
after transplantation). The rationale for using
abatacept was that B7-1 is induced in podocytes
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in primary and recurrent FSGS as well as in patients with membranous nephropathy.
In an attempt to reproduce their findings
with the same antibodies, we found no B7-1
signal in samples obtained from patients with
recurrent FSGS after transplantation and strong
staining in samples obtained from patients with
membranous nephropathy, results almost identical to those reported by Yu et al. However, sec-

nejm.org

march 27, 2014

The New England Journal of Medicine
Downloaded from nejm.org at UNIV OF KENTUCKY on October 16, 2015. For personal use only. No other uses without permission.
Copyright © 2014 Massachusetts Medical Society. All rights reserved.

1261

